- Home
- Publications
- Publication Search
- Publication Details
Title
Platinum(IV) Prodrugs - A Step Closer to Ehrlich's Vision?
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
Volume 2017, Issue 12, Pages 1596-1612
Publisher
Wiley
Online
2016-12-07
DOI
10.1002/ejic.201601278
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Platinum(IV) Anticancer Prodrug Targeting Nucleotide Excision Repair To Overcome Cisplatin Resistance
- (2016) Zhigang Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Combretastatin A-4 Analogue: A Dual-Targeting and Tubulin Inhibitor Containing Antitumor Pt(IV) Moiety with a Unique Mode of Action
- (2016) Xiaochao Huang et al. BIOCONJUGATE CHEMISTRY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- The Platin-X series: activation, targeting, and delivery
- (2016) Uttara Basu et al. DALTON TRANSACTIONS
- Glioblastoma multiforme targeted therapy: The Chlorotoxin story
- (2016) Or Cohen-Inbar et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin
- (2016) Juraj Zajac et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer
- (2016) James P. Parker et al. Metallomics
- Asplatin enhances drug efficacy by altering the cellular response
- (2016) Qinqin Cheng et al. Metallomics
- Activation of Platinum(IV) Prodrugs by Cytochrome c and Characterization of the Protein Binding Sites
- (2016) Alessia Lasorsa et al. MOLECULAR PHARMACEUTICS
- Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
- (2016) Raji Raveendran et al. Chemical Science
- A Photoactivatable Platinum(IV) Complex Targeting Genomic DNA and Histone Deacetylases
- (2015) Jana Kasparkova et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
- (2015) Vojtech Novohradsky et al. BIOCHEMICAL PHARMACOLOGY
- Targeted radionuclide therapies for pancreatic cancer
- (2015) M Shah et al. CANCER GENE THERAPY
- Chalcoplatin, a dual-targeting and p53 activator-containing anticancer platinum(iv) prodrug with unique mode of action
- (2015) Lili Ma et al. CHEMICAL COMMUNICATIONS
- An integrin-targeted photoactivatable Pt(iv) complex as a selective anticancer pro-drug: synthesis and photoactivation studies
- (2015) Albert Gandioso et al. CHEMICAL COMMUNICATIONS
- Anti-cancer chalcones: Structural and molecular target perspectives
- (2015) Debarshi Kar Mahapatra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine
- (2015) George Mattheolabakis et al. JOURNAL OF DRUG TARGETING
- Recent Advances in Platinum (IV) Complex-Based Delivery Systems to Improve Platinum (II) Anticancer Therapy
- (2015) Xiaopeng Han et al. MEDICINAL RESEARCH REVIEWS
- Tumor-targeting delivery of hyaluronic acid–platinum(iv) nanoconjugate to reduce toxicity and improve survival
- (2015) Xiang Ling et al. Polymer Chemistry
- Induction of targeted necrosis with HER2-targeted platinum(iv) anticancer prodrugs
- (2015) Daniel Yuan Qiang Wong et al. Chemical Science
- Design and delivery of camplatin to overcome cisplatin drug resistance
- (2015) Ruogu Qi et al. Journal of Materials Chemistry B
- New developments in the treatment of peripheral T-cell lymphoma – role of Belinostat
- (2015) Peter Reimer Cancer Management and Research
- Immuno-Chemotherapeutic Platinum(IV) Prodrugs of Cisplatin as Multimodal Anticancer Agents
- (2014) Daniel Yuan Qiang Wong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
- (2014) Rakesh K. Pathak et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
- (2014) Qinqin Cheng et al. CHEMICAL COMMUNICATIONS
- On the Stability of PtIVPro-Drugs with Haloacetato Ligands in the Axial Positions
- (2014) Ezequiel Wexselblatt et al. CHEMISTRY-A EUROPEAN JOURNAL
- Copper-Free Click-Chemistry Platform to Functionalize Cisplatin Prodrugs
- (2014) Rakesh K. Pathak et al. CHEMISTRY-A EUROPEAN JOURNAL
- Conjugates of Cisplatin and Cyclooxygenase Inhibitors as Potent Antitumor Agents Overcoming Cisplatin Resistance
- (2014) Wilma Neumann et al. ChemMedChem
- Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
- (2014) Wilma Neumann et al. ChemMedChem
- Molecular Targeted Approaches to Cancer Therapy and Prevention Using Chalcones
- (2014) Danielle Jandial et al. CURRENT CANCER DRUG TARGETS
- Pros and cons of bifunctional platinum(iv) antitumor prodrugs: two are (not always) better than one
- (2014) Elisabetta Gabano et al. DALTON TRANSACTIONS
- A New Entry to Asymmetric Platinum(IV) Complexes via Oxidative Chlorination
- (2014) Mauro Ravera et al. INORGANIC CHEMISTRY
- New and emerging HDAC inhibitors for cancer treatment
- (2014) Alison C. West et al. JOURNAL OF CLINICAL INVESTIGATION
- Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
- (2014) Vojtech Novohradsky et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- COX-2 as a target for cancer chemotherapy
- (2014) Nilanjan Ghosh et al. Pharmacological Reports
- Glutathione S-conjugates as prodrugs to target drug-resistant tumors
- (2014) Emma E. Ramsay et al. Frontiers in Pharmacology
- Pharmacogenomics of Cisplatin Sensitivity in Non-small Cell Lung Cancer
- (2014) Maimon C. Rose et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Nanoparticle Encapsulation of Mitaplatin and the Effect Thereof on In Vivo Properties
- (2013) Timothy C. Johnstone et al. ACS Nano
- Platinum(IV) Prodrugs with Haloacetato Ligands in the Axial Positions can Undergo Hydrolysis under Biologically Relevant Conditions
- (2013) Ezequiel Wexselblatt et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Conjugation of vitamin E analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy
- (2013) Kogularamanan Suntharalingam et al. CHEMICAL COMMUNICATIONS
- Synthetic Methods for the Preparation of Platinum Anticancer Complexes
- (2013) Justin J. Wilson et al. CHEMICAL REVIEWS
- Phase II Study of Satraplatin and Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Pharmacogenetic Assessment of Outcome and Toxicity
- (2013) William D. Figg et al. Clinical Genitourinary Cancer
- Targeted delivery of platinum-based anticancer complexes
- (2013) Jennifer S Butler et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
- (2013) Manuela Alessio et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- A novel platinum complex of the histone deacetylase inhibitor belinostat: Rational design, development and in vitro cytotoxicity
- (2013) James P. Parker et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Camphor—A Fumigant during the Black Death and a Coveted Fragrant Wood in Ancient Egypt and Babylon—A Review
- (2013) Weiyang Chen et al. MOLECULES
- Review of Clinical Trials for Mitochondrial Disorders: 1997–2012
- (2013) Douglas S. Kerr Neurotherapeutics
- Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer
- (2013) Ulka N. Vaishampayan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Enzyme Inhibition as a Key Target for the Development of Novel Metal-Based Anti-Cancer Therapeutics
- (2012) Darren Griffith et al. Anti-Cancer Agents in Medicinal Chemistry
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Facile Preparation of Mono-, Di- and Mixed-Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design
- (2012) Jenny Z. Zhang et al. CHEMISTRY-A EUROPEAN JOURNAL
- Solid-phase synthesis of oxaliplatin–TAT peptide bioconjugates
- (2012) Sergey Abramkin et al. DALTON TRANSACTIONS
- Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent
- (2012) Marilù Sinisi et al. INORGANIC CHEMISTRY
- Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells
- (2012) Nora Graf et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(iv)–peptide bioconjugates
- (2012) Luca Gaviglio et al. Metallomics
- Trans,trans,trans-[PtIV(N3)2(OH)2(py)(NH3)]: A Light-Activated Antitumor Platinum Complex That Kills Human Cancer Cells by an Apoptosis-Independent Mechanism
- (2012) A. F. Westendorf et al. MOLECULAR CANCER THERAPEUTICS
- Mitaplatin Increases Sensitivity of Tumor Cells to Cisplatin by Inducing Mitochondrial Dysfunction
- (2012) Xue Xue et al. MOLECULAR PHARMACEUTICS
- Valuable Insight into the Anticancer Activity of the Platinum-Histone Deacetylase Inhibitor Conjugate, cis-[Pt(NH3)2malSAHA–2H)]
- (2012) Viktor Brabec et al. MOLECULAR PHARMACEUTICS
- Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
- (2012) Jun Yang et al. MOLECULAR PHARMACEUTICS
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Will an Aspirin a Day Keep Cancer Away?
- (2012) J. Kaiser SCIENCE
- Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer
- (2012) M. Fani et al. Theranostics
- Trastuzumab: Updated Mechanisms of Action and Resistance in Breast Cancer
- (2012) Thuy Vu et al. Frontiers in Oncology
- Pt(iv) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate
- (2011) Jenny Z. Zhang et al. CHEMICAL COMMUNICATIONS
- Studies of Glutathione Transferase P1-1 Bound to a Platinum(IV)-Based Anticancer Compound Reveal the Molecular Basis of Its Activation
- (2011) Lorien J. Parker et al. CHEMISTRY-A EUROPEAN JOURNAL
- Evaluation of Platinum-Ethacrynic Acid Conjugates in the Treatment of Mesothelioma
- (2011) Ilaria Zanellato et al. ChemMedChem
- Histone deacetylase inhibitors in the generation of the anti-tumour immune response
- (2011) Graham R Leggatt et al. IMMUNOLOGY AND CELL BIOLOGY
- Novel trans-platinum complexes of the histone deacetylase inhibitor valproic acid; synthesis, in vitro cytotoxicity and mutagenicity
- (2011) Darren M. Griffith et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Pt(IV) complexes as prodrugs for cisplatin
- (2011) Yi Shi et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Prodrugs--from Serendipity to Rational Design
- (2011) K. M. Huttunen et al. PHARMACOLOGICAL REVIEWS
- New reduction pathways for ctc-[PtCl2(CH3CO2)2(NH3)(Am)] anticancer prodrugs
- (2010) Alina Nemirovski et al. CHEMICAL COMMUNICATIONS
- The status of platinum anticancer drugs in the clinic and in clinical trials
- (2010) Nial J. Wheate et al. DALTON TRANSACTIONS
- Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes
- (2010) Michael R. Reithofer et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- HDAC inhibitors, MS275 and SBHA, enhances cytotoxicity induced by oxaliplatin in the colorectal cancer cell lines
- (2009) Sylwia Flis et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
- (2009) Darren Griffith et al. CHEMICAL COMMUNICATIONS
- Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial
- (2009) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression
- (2009) Sandra Dupouy et al. PLoS One
- Mitaplatin, a potent fusion of cisplatin and the orphan drug dichloroacetate
- (2009) Shanta Dhar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel Endothall-Containing Platinum(IV) Complexes: Synthesis, Characterization, and Cytotoxic Activity
- (2008) Michael R. Reithofer et al. CHEMISTRY & BIODIVERSITY
- Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue
- (2008) H. Choy et al. CLINICAL CANCER RESEARCH
- Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- (2007) Sumitra Mukhopadhyay et al. BIOCONJUGATE CHEMISTRY
- Insight into the reactive form of the anticancer agent iproplatin
- (2007) Erika Volckova et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started